Liberty is the cannabis provider committed to providing a trusted, high quality cannabis experience based on our genuine care for all cannabis users and a focus on operational excellence from seed to sale. Liberty’s measured approach to expansion opportunities is focused on maximizing returns to shareholders, while keeping consumers’ well-being at the forefront of what we do.

Liberty Health Sciences Inc. is a producer and retailer of cannabis products aimed at improving the quality of peoples’ lives. Liberty’s focus is solely on the United States market where it produces high-quality products at a low cost. Through its wholly-owned subsidiary, DFMMJ Investments, LLC (d/b/a Liberty Health Sciences Florida Ltd.) (“Liberty Florida”), Liberty is licensed to produce and sell medical cannabis products in Florida.

The Company is focused on acquiring other cannabis business and expanding its operations throughout the United States.

Liberty’s common shares (the “Common Shares”) are listed under the symbol “LHS” on the Canadian Securities Exchange (“CSE”) and the OTC Markets OTCQX Best Market (“OTCQX”) in the United States under the symbol “LHSIF”.

Through fiscal 2019, Liberty opened a total of nine dispensaries throughout the State of Florida. Another five dispensaries were opened subsequent to year end, bringing Liberty’s total dispensary count to fifteen in June 2019. The Company has lease agreements in place for another six locations and is further negotiating another six. Liberty plans on opening up to thirty dispensaries by the end of fiscal 2020. During fiscal 2019, to better serve Florida’s expanding patient base, Liberty invested in expanding its delivery abilities, providing customers with door-to-door services and building six major delivery hubs. Subsequent to the fiscal year end, Liberty integrated the operations of their delivery hubs into existing dispensaries in order to reduce overhead costs, and now delivers statewide out of Dania Beach, St. Petersburg, Tallahassee, Bonita Springs, Merritt Island and Gainesville.


View Financials

Meetings & Events

Meetings & Events

Investor Relations

Contact IR

SEDAR Filings

View Filings

The medical cannabis marketplace in Florida is in its early stages, which is evidenced by the fact that approximately 307,000 patients have been added to the Medical Marijuana Use Registry as of June 2019 statewide. With over 20 million residents, Florida’s potential patient base is vast. The patient registration volume has grown significantly in recent months as more supply has become available and as access to the growing number of physicians who are qualified to recommend medical cannabis has expanded, which has resulted in more than a quadrupling of registered patients since the beginning of 2018. There are now over 2,321 qualified physicians in the State of Florida who can access medical cannabis for their patients. Patient volume is expected to continue increasing at a rapid pace considering the expanded medical uses as well as the broad availability of high THC products, as well as the introduction of smokeable flower products to the Florida market. With expanded production capabilities, a primary goal of the business moving forward is the acquisition of qualified patients